0.0531
Applied Dna Sciences Inc stock is traded at $0.0531, with a volume of 14.08M.
It is down -16.38% in the last 24 hours and down -69.52% over the past month.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
See More
Previous Close:
$0.0635
Open:
$0.062
24h Volume:
14.08M
Relative Volume:
2.87
Market Cap:
$2.93M
Revenue:
$9.00M
Net Income/Loss:
$-7.21M
P/E Ratio:
-0.0965
EPS:
-0.55
Net Cash Flow:
$-7.59M
1W Performance:
-59.03%
1M Performance:
-69.52%
6M Performance:
-96.12%
1Y Performance:
-99.45%
Applied Dna Sciences Inc Stock (APDN) Company Profile
Name
Applied Dna Sciences Inc
Sector
Industry
Phone
631-240-8800
Address
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Compare APDN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
APDN
Applied Dna Sciences Inc
|
0.0531 | 2.93M | 9.00M | -7.21M | -7.59M | -0.55 |
![]()
TMO
Thermo Fisher Scientific Inc
|
508.90 | 191.99B | 42.88B | 6.34B | 7.27B | 16.53 |
![]()
DHR
Danaher Corp
|
204.09 | 145.87B | 23.88B | 3.90B | 5.30B | 5.28 |
![]()
A
Agilent Technologies Inc
|
117.33 | 33.47B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IDXX
Idexx Laboratories Inc
|
406.29 | 33.04B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
IQV
Iqvia Holdings Inc
|
181.43 | 31.99B | 15.41B | 1.37B | 2.11B | 7.50 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-12-21 | Initiated | ROTH Capital | Buy |
Jan-14-21 | Reiterated | H.C. Wainwright | Buy |
Dec-18-20 | Reiterated | H.C. Wainwright | Buy |
Jul-20-20 | Reiterated | H.C. Wainwright | Buy |
Jul-02-20 | Initiated | H.C. Wainwright | Buy |
Nov-14-16 | Reiterated | Maxim Group | Buy |
May-13-16 | Reiterated | Maxim Group | Buy |
Oct-08-15 | Reiterated | Maxim Group | Buy |
May-26-15 | Initiated | The Benchmark Company | Speculative Buy |
Feb-10-15 | Reiterated | Maxim Group | Buy |
Jan-13-15 | Initiated | Maxim Group | Buy |
View All
Applied Dna Sciences Inc Stock (APDN) Latest News
Applied DNA announces 1-for-50 reverse stock split - MSN
APDN stock plunges to 52-week low of $0.09 amid market challenges - Investing.com
Applied DNA Sciences Approves Reverse Stock Split - TipRanks
Applied DNA Sciences to Implement 1-for-50 Reverse Stock Split; Shares Fall -March 12, 2025 at 11:14 am EDT - Marketscreener.com
Applied DNA announces 1-for-50 reverse stock split By Investing.com - Investing.com Australia
Applied DNA Sciences Says 1-For-50 Reverse Stock Split Of Issued And Outstanding Common Stock Effective March 14 - Marketscreener.com
APDN stock plunges to 52-week low of $0.09 amid market challenges By Investing.com - Investing.com South Africa
Applied DNA Sciences announces 1-for-50 reverse stock split - TipRanks
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025 - Eagle-Tribune
Applied DNA Sciences Announces Major Share Consolidation to Maintain Nasdaq Listing - StockTitan
Applied DNA Sciences, Inc. to Host Earnings Call - ACCESS Newswire
Balance Sheet Breakdown: Applied Dna Sciences Inc (APDN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Here’s Why Applied Dna Sciences Inc (NASDAQ: APDN) Is A Good Stock To Buy Right Now - Stocks Register
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - ACCESS Newswire
Applied DNA Sciences fails to secure quorum at special meeting By Investing.com - Investing.com South Africa
Applied DNA Sciences fails to secure quorum at special meeting - Investing.com
Applied DNA Sciences fails to secure quorum at meeting - MSN
Applied DNA signals growth with GMP facility launch and LineaRx focus in 2025 - MSN
Applied DNA Sciences fails to secure quorum at meeting By Investing.com - Investing.com Australia
Applied DNA Sciences Inc. Earnings Call Highlights Mixed Sentiment - TipRanks
Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates - MSN
Earnings call transcript: Applied DNA Sciences Q1 FY25 revenue grows - MSN
Applied DNA Sciences Inc (APDN) Q1 2025 Earnings Call Highlights - GuruFocus.com
Applied DNA Sciences Inc (APDN) Q1 2025 Earnings Call Highlights: Strategic Restructuring and ... - Yahoo Finance
Applied DNA Sciences Inc. Reports Restructuring and Revenue Growth - TipRanks
Earnings call transcript: Applied DNA Sciences Q1 FY25 revenue grows By Investing.com - Investing.com Nigeria
Applied DNA Sciences Inc. (APDN) reports earnings - Quartz
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot - San Francisco Chronicle
Applied DNA Sciences Reports First Quarter Fiscal 2025 Financial Results - TradingView
APPLIED DNA SCIENCES INC SEC 10-Q Report - TradingView
Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress - Milton Daily Standard
Applied DNA Sciences Unveils Major Strategic Overhaul as Q1 Revenue Surges 34% - StockTitan
Things To Consider Before You Buy Applied Dna Sciences Inc (NASDAQ: APDN) - Stocks Register
Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025 - WICZ
Earnings Alert: Applied DNA Sets Q1 2025 Results DateKey Details for Investors - StockTitan
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14 - Chronicle-Tribune
Applied DNA (APDN) Urges Shareholders: Last Chance to Vote on Strategic Warrant Proposal - StockTitan
Applied Dna Sciences Inc (APDN) gets rating Initiated from ROTH Capital - Knox Daily
Analyzing Ratios: Applied Dna Sciences Inc (APDN)’s Financial Story Unveiled - The Dwinnex
Applied DNA Sciences (APDN) Projected to Post Quarterly Earnings on Thursday - Defense World
A History of Outperforming Analyst Forecasts and Beating the Odds: Applied Dna Sciences Inc (APDN) - SETE News
Breaking down APDN’s current quarter earnings estimates - US Post News
Applied DNA Sciences Announces Change in Certifying Accountant – Form 8-K Filing - Defense World
Applied DNA Sciences Appoints New Auditor By Investing.com - Investing.com South Africa
Applied DNA Sciences Appoints New Auditor - Investing.com
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health - ACCESS Newswire
Applied Dna Sciences Inc Stock (APDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):